INO - イノバロン・ホ―ルドング （Inovio Pharmaceuticals Inc.） イノバロン・ホ―ルドングINOのチャート
INOの企業情報
| symbol | INO |
|---|---|
| 会社名 | Inovalon Holdings Inc （イノバロン・ホ―ルドング） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | バイオテクノロジ―_メディカルリサ―チ IT・通信（IT_Communications） |
| 概要 | 事業概要 アイノビオ・ファーマスーティカル(Inovio Pharmaceuticals Inc.)は癌と感染症の治療・予防に従事するデオキシリボ核酸（DNA）免疫療法とワクチンの開発を行う臨床段階の製薬会社である。同社のDNAベースの免疫療法はエレクトロポレーション送達デバイスと組み合わせて、標的疾患と戦う体内にある免疫応答、特にT細胞を生成する。同社はヒトパピローマウイルス（HPV）に起因する前癌・癌、インフルエンザ、前立腺癌、乳癌・肺癌・膵臓癌、C型肝炎ウイルス（HCV）、B型肝炎ウイルス（HBV）、ヒト免疫不全ウイルス（HIV）、エボラ、中東呼吸器症候群（MERS）及びジーファウイルスに対するSynCon免疫療法の臨床計画を完成する。同社は免疫療法プラットフォーム及びCELLECTRAエレクトロポレーション送達技術により、インビボ免疫応答を生じる前臨床・臨床段階製品のパイプラインを所有する。 イノバロン・ホ―ルドングは、米国の持株会社。医療にクラウドベ―スのデ―タ分析とデ―タ駆動介入プラットフォ―ムを組み合せた技術展開する。分析では、ケア、品質、デ―タの整合性、および財務実績のギャップを特定する。この差別組み合わせは、計画、病院、医師、患者、製薬会社や研究者のためのプラットフォ―ムを提供する。 INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with HPV. INOVIO is the first and only company to have clinically demonstrated that a DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. INOVIO's lead immunotherapy candidate, VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, cleared high-risk HPV-16 and/or HPV-18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 91% of anal cancer, and 69% of vulvar cancer. Also in development are programs targeting HPV-related cancers and a rare HPV-related disease, recurrent respiratory papillomatosis (RRP); non-HPV-related cancers glioblastoma multiforme (GBM) and prostate cancer; as well as infectious disease DNA vaccine development programs in coronaviruses associated with COVID-19 diseases and MERS, Lassa fever, Ebola, and HIV. Partners and collaborators include Advaccine, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA)/Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)/Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute (IVI), Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Richter-Helm BioLogics, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. INOVIO also is a proud recipient of 2020 Women on Boards 'W' designation recognizing companies with more than 20% women on their board of directors. |
| 本社所在地 | 4321 Collington Road Bowie MD 20716 USA |
| 代表者氏名 | Jong Joseph Kim ジョン・ジョセフ・キム |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 858-410-3134 |
| 設立年月日 | 41883 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 2480人 |
| url | www.inovalon.com |
| nasdaq_url | https://www.nasdaq.com/symbol/ino |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -86.82719 |
| 終値（lastsale） | 5.37 |
| 時価総額（marketcap） | 491338003.95 |
| 時価総額 | 時価総額（百万ドル） 497.74280 |
| 売上高 | 売上高（百万ドル） 37.41017 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 402.14780 |
| 当期純利益 | 当期純利益（百万ドル） -94.63071 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Inovio Pharmaceuticals Inc revenues decreased 16% to $26M. Net loss increased 20% to $39M. Revenues reflect Grants and miscellaneous revenue decrease of 99% to $95K Grants and miscellaneous revenue from af decrease from $1.7M to $0K Revenue under collaborative research and decrease of 49% to $208K. Higher net loss reflects General and administrative - Balancing v increase of 50% to $14.6M (expense). |
INOのテクニカル分析
INOのニュース
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Could Fell By How Much? 2022/10/04 12:00:00 Stocks Register
The trading price of Inovio Pharmaceuticals Inc. (NASDAQ:INO) closed lower on Monday, October 03, closing at $1.72, -0.29% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.66 and $1.79. In examining the 52-week price action we see that the stock hit a 52-week … Inovio Pharmaceuticals Inc. (NASDAQ: INO) Could Fell By How Much? Read More »
Choosing between riding the trend or protecting profits: Inovio Pharmaceuticals Inc. (INO) 2022/09/30 18:16:00 US Post News
Inovio Pharmaceuticals Inc. (INO)’s stock has witnessed a price hike of 4.52% from the previous close with its current price standing at $1.76. Its current price is -77.40% under its 52-week high of $7.77 and 27.24% more than its 52-week low of $1.38. Based on the past 30-day period, the stock price is -29.13% below […]
Inovio Stock: Long On Promise, Short On Results (NASDAQ:INO) 2022/09/27 06:09:12 Seeking Alpha
Inovio Pharma had a massive spike up in mid-2020 but has been going down since. Is this a buying opportunity or should you continue to avoid INO stock? Find out.
Our Attention Has Been Attracted to Inovio Pharmaceuticals Inc. (NASDAQ:INO) 2022/09/26 16:32:00 US Post News
Inovio Pharmaceuticals Inc. (INO)’s stock has witnessed a price hike of 2.63% from the previous close with its current price standing at $1.75. Its current price is -78.17% under its 52-week high of $8.04 and 27.17% more than its 52-week low of $1.38. Based on the past 30-day period, the stock price is -26.03% below […]
How did Inovio Pharmaceuticals Inc. (INO) fare last session? 2022/09/20 13:00:00 US Post News
A share of Inovio Pharmaceuticals Inc. (NASDAQ:INO) closed at $1.85 per share on Monday, down from $1.93 day before. While Inovio Pharmaceuticals Inc. has underperformed by -4.15%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, INO fell by -77.27%, with highs and lows ranging from $8.15 […]
Inovio Pharmaceuticals Inc. (NASDAQ: INO): What’s Next In 2022? 2022/06/03 12:00:00 Stocks Register
Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares, rose in value on Thursday, 06/02/22, with the stock price up by 2.27% to the previous day’s close as strong demand from buyers drove the stock to $1.80. Actively observing the price movement in the last trading, the stock closed the session at $1.76, falling within a range of $1.74 … Inovio Pharmaceuticals Inc. (NASDAQ: INO): What’s Next In 2022? Read More »
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Stock Forecast 2022: Profitable With Bullish Signals 2022/05/31 19:00:00 Marketing Sentinel
In today’s recent session, 1.76 million shares of the Inovio Pharmaceuticals Inc. (NASDAQ:INO) have been traded, and its beta is 0.86. Most recently the company’s share price was $1.94, and it changed around -$0.05 or -2.51% from the last close, which brings the market valuation of the company to $400.81M. INO at last check was … Inovio Pharmaceuticals Inc. (NASDAQ: INO) Stock Forecast 2022: Profitable With Bullish Signals Read More »
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Has Succeeded In Generating Interest In 2022, The Stock Is Down -64.93% Year-To-Date 2022/05/27 15:30:00 Marketing Sentinel
Inovio Pharmaceuticals Inc. (NASDAQ:INO)’s traded shares stood at 4.27 million during the last session, with the company’s beta value hitting 0.90. At the close of trading, the stock’s price was $1.75, to imply an increase of 1.16% or $0.02 in intraday trading. The INO share’s 52-week high remains $10.33, putting it -490.29% down since that … Inovio Pharmaceuticals Inc. (NASDAQ: INO) Has Succeeded In Generating Interest In 2022, The Stock Is Down -64.93% Year-To-Date Read More »
Why Inovio Pharmaceuticals Stock Is Rising Today 2022/05/23 13:34:49 Benzinga
Inovio Pharmaceuticals Inc (NASDAQ: INO ) shares are trading higher Monday amid increasing monkeypox concerns. A monkeypox outbreak has been reported in at least a dozen countries. There has been one confirmed case in the United States and at least one other case is suspected. President Biden on Sunday warned … Full story available on Benzinga.com
Thinking about buying stock in SIGA Technologies, Geovax Labs, Inovio Pharmaceuticals, ImmunoGen, or Emergent Biosolutions? 2022/05/23 12:30:00 Benzinga
NEW YORK , May 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SIGA, GOVX, INO, IMGN, and EBS. … Full story available on Benzinga.com
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Stock Forecast 2022: Profitable With Bullish Signals 2022/05/31 19:00:00 Marketing Sentinel
In today’s recent session, 1.76 million shares of the Inovio Pharmaceuticals Inc. (NASDAQ:INO) have been traded, and its beta is 0.86. Most recently the company’s share price was $1.94, and it changed around -$0.05 or -2.51% from the last close, which brings the market valuation of the company to $400.81M. INO at last check was … Inovio Pharmaceuticals Inc. (NASDAQ: INO) Stock Forecast 2022: Profitable With Bullish Signals Read More »
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Has Succeeded In Generating Interest In 2022, The Stock Is Down -64.93% Year-To-Date 2022/05/27 15:30:00 Marketing Sentinel
Inovio Pharmaceuticals Inc. (NASDAQ:INO)’s traded shares stood at 4.27 million during the last session, with the company’s beta value hitting 0.90. At the close of trading, the stock’s price was $1.75, to imply an increase of 1.16% or $0.02 in intraday trading. The INO share’s 52-week high remains $10.33, putting it -490.29% down since that … Inovio Pharmaceuticals Inc. (NASDAQ: INO) Has Succeeded In Generating Interest In 2022, The Stock Is Down -64.93% Year-To-Date Read More »
Why Inovio Pharmaceuticals Stock Is Rising Today 2022/05/23 13:34:49 Benzinga
Inovio Pharmaceuticals Inc (NASDAQ: INO ) shares are trading higher Monday amid increasing monkeypox concerns. A monkeypox outbreak has been reported in at least a dozen countries. There has been one confirmed case in the United States and at least one other case is suspected. President Biden on Sunday warned … Full story available on Benzinga.com
Thinking about buying stock in SIGA Technologies, Geovax Labs, Inovio Pharmaceuticals, ImmunoGen, or Emergent Biosolutions? 2022/05/23 12:30:00 Benzinga
NEW YORK , May 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SIGA, GOVX, INO, IMGN, and EBS. … Full story available on Benzinga.com